Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population

被引:21
|
作者
Yin, Jiaoyang [1 ,6 ]
Vogel, Ulla [2 ,3 ]
Ma, Yegang [4 ]
Qi, Rong [1 ,6 ]
Wang, Huiwen [5 ]
机构
[1] Univ Liaoning Prov, Shenyang Med Coll, Key Lab Environm & Populat Hlth, Shenyang 110034, Liaoning Prov, Peoples R China
[2] Natl Res Ctr Working Environm, DK-2100 Copenhagen O, Denmark
[3] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark
[4] Liaoning Canc Hosp, Dept Thorac Surg, Shenyang 110042, Liaoning Prov, Peoples R China
[5] Shenyang Med Coll, Dept Epidemiol, Shenyang 110034, Liaoning Prov, Peoples R China
[6] Shenyang Med Coll, Dept Cell Biol & Genet, Shenyang 110034, Liaoning Prov, Peoples R China
基金
中国国家自然科学基金;
关键词
chromosome; 19q13.2-3; DNA repair gene; single nucleotide polymorphism; haplotype; lung cancer; Chinese population;
D O I
10.1016/j.mrfmmm.2008.02.004
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To evaluate the joint effect of nine single nucleotide polymorphisms for three DNA repair genes in the region of chromosome 19q13.2-3 on susceptibility of lung cancer in a Chinese population, we conducted a hospital-based case-control study consisting of 247 lung cancer cases and 253 cancer-free controls matched on age, gender and ethnicity. Associations between the haplotypes and susceptibility of lung cancer were tested. The global test of haplotype association revealed a statistically significant difference in the haplotype distribution between cases and controls (global test: chi(2) = 60.45, d.f. = 15, P = 2.11E-07). The two haplotypes were underrepresented among cases (Hap5 defined by ERCC1118(A)-ERCC2156(C)-ERCC2312(G)-ERCC2751(A)-XRCC1194(T)-XRCC1206(A) -XRCC1280(G)-XRCC1399(G)-XRCC1632(G) and Hap12 defined by ERCC1118(G)-ERCC2156(C)-ERCC2312(G)-ERCC2751A-XRCC1194(C)-XRCC1206(A) -XRCC1280(G)-XRCC1399(A)-XRCC1632(G)). Three of the haplotypes were overrepresented among cases (Hap3 defined by ERCC1118(A) -ERCC2156(C)-ERCC2312(G)-ERCC2751(A)-XRCC1194(C)-XRCC1206(A)-XRCC1280(G)-XRCC1399(G)-XRCC1632(G) Hap4 defined by ERCC1118(A) -ERCC2156(C)-ERCC2312(G)-ERCC2751(A)-XRCC1194(C)-XRCC1206(G)-XRCC1280(G)-XRCC1399(G)-XRCC1632(A) and Hap10 defined by ERCC1118(G)-ERCC2156(A)-ERCC2312(G)-ERCC2751(A)-XRCC1194(T)-XRCC1206(A)-XRCC1280(G)-XRCC1399(G)-XRCC1632(G)). Haplotypes 3 and 10 (cases = 5.7%, controls = 1.0%, OR = 6.56, 95%CI = 1.83-23.54, P = 0.001; cases = 13.3%, controls = 5.6%, OR = 2.73, 95%CI = 1.51-4.94, P = 0.0006) were the most strongly associated with increased lung cancer risk. There was considerable linkage disequilibrium exists between SNPs both within genes and between genes in the region. The two blocks for solid spine of LD and six htSNPs were found. The haplotype analysis suggested that the biologically effective polymorphisms co-segregate with some of the haplotypes. This result supports the hypothesis that the sub-region is important for lung cancer susceptibility. Haplotype studies using larger study groups will be required to obtain conclusive results. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [1] Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer
    Vogel, U
    Laros, I
    Jacobsen, NR
    Thomsen, BL
    Bak, H
    Olsen, A
    Bukowy, Z
    Wallin, H
    Overvad, K
    Tjonneland, A
    Nexo, BA
    Raaschou-Nielsenc, O
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 546 (1-2) : 65 - 74
  • [2] Multiple single nucleotide polymorphisms on human chromosome 19q13.2-3 associate with risk of basal cell carcinoma
    Yin, JY
    Rockenbauer, E
    Hedayati, M
    Jacobsen, NR
    Vogel, U
    Grossman, L
    Bolund, L
    Nexo, BA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1449 - 1453
  • [3] Association of chromosome 19q13.2-3 haplotypes with basal cell carcinoma: tentative delineation of an involved region using data for single nucleotide polymorphisms in two cohorts
    Rockenbauer, E
    Bendixen, MH
    Bukowy, Z
    Yin, JY
    Jacobsen, NR
    Hedayati, M
    Vogel, U
    Grossman, L
    Bolund, L
    Nexo, BA
    CARCINOGENESIS, 2002, 23 (07) : 1149 - 1153
  • [4] A specific haplotype of single nucleotide polymorphisms on chromosome 19q13.2-3 encompassing the gene RAI is indicative of post-menopausal breast cancer before age 55
    Nexo, BA
    Vogel, U
    Olsen, A
    Ketelsen, T
    Bukowy, Z
    Thomsen, BL
    Wallin, H
    Overvad, K
    Tjonneland, A
    CARCINOGENESIS, 2003, 24 (05) : 899 - 904
  • [5] Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population
    Jia, Ziqi
    Huang, Yansong
    Liu, Jiaqi
    Liu, Gang
    Li, Jiayi
    Xu, Hengyi
    Jiang, Yiwen
    Zhang, Song
    Wang, Yidan
    Chen, Gang
    Qiao, Guangdong
    Li, Yalun
    GENE, 2023, 884
  • [6] Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population
    Liang, GY
    Pu, YP
    Yin, LH
    CANCER LETTERS, 2005, 223 (02) : 265 - 274
  • [7] Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of chinese population
    Liang Ge-yu
    Pu Yue-pu
    Yin Li-hong
    PROCEEDINGS OF THE 3RD INTERNATIONAL ACADEMIC CONFERENCE ON ENVIRONMENTAL AND OCCUPATIONAL MEDICINE, 2006, : 138 - 142
  • [8] The search for cancer modifier genes using single nucleotide polymorphisms at human chromosome 20q13.2.
    Toland, AE
    de Koning, J
    Mao, J
    Conrad, P
    Balmain, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 331 - 331
  • [9] Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer
    Liu, Dan
    Gao, Ya
    Li, Lingling
    Chen, He
    Bai, Lu
    Qu, Yanli
    Zhou, Baosen
    Yan, Ying
    Zhao, Yuxia
    ONCOLOGY LETTERS, 2021, 21 (05)
  • [10] Functional XPF polymorphisms associated with lung cancer susceptibility in a Chinese population
    Yu D.-K.
    Wu C.
    Tan W.
    Lin D.-X.
    Frontiers of Medicine in China, 2010, 4 (1): : 82 - 89